Skip to main content
BALCHEM CORP logo

BALCHEM CORP — Investor Relations & Filings

Ticker · BCPC ISIN · US0576652004 LEI · 549300VR70OPMHUI3557 US Manufacturing
Filings indexed 1,262 across all filing types
Latest filing 2017-12-19 Board/Management Inform…
Country US United States of America
Listing US BCPC

About BALCHEM CORP

https://balchem.com/

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products. The company operates through three primary segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health division is a leader in essential nutrients like choline, chelated minerals, and vitamin K2, utilizing advanced microencapsulation technologies for the food and nutritional supplement markets. The Animal Nutrition & Health segment provides a portfolio of products to meet the nutritional needs of animals, with a key position in choline chloride. The Specialty Products segment includes Performance Gases for various industrial applications and Plant Nutrition solutions. Balchem is focused on delivering innovative, science-based solutions to improve health and nutrition.

Recent filings

Filing Released Lang Actions
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes the election of a new director to the Board, the anticipated retirement of an existing director, and amendments to the company's Bylaws regarding Board composition. These topics fall under changes in the company's board of directors and governance structure. There is no financial data or detailed financial performance information, so it is not an Annual Report or Interim Report. The document is not a proxy solicitation or voting results announcement. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is sufficient and contains substantive information about management changes, not just an announcement of a report publication or certification. Confidence is high due to clear references to director election and bylaw amendments affecting board structure.
2017-12-19 English
8-K
Notice of Dividend Amount Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce specific events. The text indicates that the filing announces a dividend declared by the Board of Directors, referencing a press release attached as Exhibit 99.1. The document length is short (2837 characters), and it primarily serves as an announcement of the dividend declaration rather than the detailed dividend report itself. According to the classification rules, announcements of dividend amounts and payment details fall under the category 'Notice of Dividend Amount' (DIV). Therefore, this filing is best classified as a Notice of Dividend Amount (DIV).
2017-12-15 English
FORM 4
Director's Dealing
2017-12-15 English
FORM 4
Director's Dealing
2017-12-15 English
FORM 4
Director's Dealing
2017-12-13 English
IRANNOTICE
Regulatory Filings Classification · 95% confidence The document is a short notice letter addressed to the SEC referencing disclosures made in previously filed Quarterly Reports on Form 10-Q. It specifically mentions compliance with the Iran Threat Reduction and Syria Human Rights Act and the Exchange Act. The document itself does not contain financial data or the full quarterly report but serves as a certification or attestation regarding prior filings. Given its brevity (1195 characters) and nature as a notice rather than a full report, it fits the criteria for a Regulatory Filing (RNS) rather than an Interim/Quarterly Report (IR) or any other category.
2017-11-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.